E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/23/2019 in the Prospect News Convertibles Daily.

Pinduoduo pricing notes; Fortive trades in size; SailPoint, Etsy trade; Avadel stock up

By Rebecca Melvin

New York, Sept. 23 – Pinduoduo Inc. announced after the market close on Tuesday plans to sell $875 million five-year convertible senior notes.

The new e-commerce platform said it will use the proceeds to enhance and expand its business. The Rule 144A and Regulation S offering was being talked at a coupon range of 0% to 0.25% and an initial conversion premium of 32.5% to 37.5%. Final terms were expected to be set after the market close on Tuesday.

Back in secondary market action, some of the newer deals remained in focus, but there were also a few stalwart issues that were drawn into trade as U.S. stock indices wavered but eventually pushed higher.

SailPoint Technologies Holdings Inc.’s 0.125% notes and Etsy Inc.’s 0.125% convertibles, both of which priced last week, were active in trade. The SailPoint convertibles were knocking around at just below par with the underlying shares little changed at $20.55.

But Etsy’s convertibles were up 1.7 points to 102.06, according to Trace data, with the underlying shares better at as high as $61.50 in early afternoon trading. But shares dropped back to about the flat line into the market close to $60.54.

Most of the active names were consistent in terms of volume of trade in a market that was described as “pretty quiet” by a New York-based market source. But Fortive Corp.’s 0.875% convertible due 2022 was the top volume issue of the session. And volume of trade in that name at $20.5 million of bonds was double the volume of the next most actives.

There were some $5 million-plus trades, with the bonds at 98.5 bid, 98.625 offered with shares closing off a quarter, or 0.4%, at $67.95. So some decent size went through, a New York-based market source said.

Elsewhere, Avadel Pharmaceuticals plc’s 4.5% convertibles traded at 65.25 in the early going as the American Depositary Shares of the Dublin, Ireland-based specialty pharmaceutical company surged more than 30% on U.S. regulatory approval of its proposed amendments to a statistical analysis plan for the REST-ON phase 3 study for once-nightly sodium oxybate, FT218.

No modifications were made to the fundamental design of the study, including the primary or secondary endpoints, closing scheme or duration of the study, according to a news report.

The company filed for Chapter 11 bankruptcy protection in February; and the Avadel bonds traded against $4.38 on the stock.

The Avadel convertible is a $125 million issue.

Meanwhile, Insulet Corp.’s older 1.375% convertibles due 2024 – not the new ones – were trading a little below double par, with the shares of the Billerica, Mass.-based medical device maker up $2.75, or 1.8%, at $158.55 last. The new $660 million Insulet 0.375% convertibles were not seen in trade.

Alder Biopharmaceuticals Inc.’s convertibles continued to trade in a range after surging more than 20 points on an outright basis last week after it was announced that the Bothell, Wash.-based developer of therapeutic monoclonal antibodies signed a definitive agreement to be acquired by H. Lundbeck A/S.

The Alder 2.5% convertibles due 2025 traded last at 110.25, which was up from 109.5 a week ago and up from about 88 prior to that, according to Trace data. Shares on Monday were unchanged at $18.62.

Among mandatory issues, Change Healthcare Inc.’s tangible equity units, which priced in June, traded down $1.25, or 2.4%, on Monday to $50.45. Change Healthcare common shares were down 1.2% to $13.08.

There was no apparent news that pulled the equity units of the Nashville, Tenn.-based health care technology company into trade. The company uses artificial Intelligence to rewrite the rules of change capture.

Mentioned in this article:

Alder Biopharmaceuticals Inc. Nasdaq: ALDR

Avadel Pharmaceuticals plc Nasdaq: ADS: AVDL

Change Healthcare Inc. Nasdaq: CHNG

Etsy Inc.:Nasdaq: ETSY
Insulet Corp.Nasdaq: PODD
Pinduoduo Inc.Nasdaq: ADS: PDD
SailPoint Technologies Holdings Inc.Nasdaq: SAIL

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.